Preparing for Ibogaine Screening: What to Gather Before a Consult

Definition box

Definition: Preparing for ibogaine screening means assembling medical history, medication lists, cardiac data, and substance-use timelines so a physician can decide whether IV ibogaine infusion—intravenous psychoactive ibogaine under continuous cardiac monitoring—is even appropriate. Screening exists because ibogaine can prolong the QTc interval and has been linked to serious cardiac events. Support IV (fluids/magnesium/antiemetics) is not the psychoactive dose. Evidence gap: Much published literature is oral observational (Cherian/MISTIC = oral ibogaine + IV magnesium only); controlled psychoactive-IV evidence is sparse. Ibogaine is U.S. Schedule I and not FDA-approved. No cures. No DIY. Mexico programs discussed here are provisional only.

Quotable answer (54 words)

Preparing for ibogaine screening means bringing a full medication list, cardiac history, recent labs if available, and an honest substance-use timeline. IV ibogaine infusion requires physician-supervised monitoring because of QTc risk; much published research remains oral. Screening can conclude you are not a candidate. That refusal is a safety outcome, not a sales failure.

Why preparation beats persuasion

People who “sell themselves” into a program by minimizing heart history or hiding SSRIs are optimizing for acceptance—not survival. Ethical screening can delay or decline care. That is a feature.

Start here: /safety-and-screening · Entity: /what-is-ibogaine-infusion · Process: /how-it-works · Apply when ready: /apply · FAQ: /faq.

Document checklist (bring what you can)

Identity & logistics - Legal name, DOB, emergency contacts - Travel constraints (if cross-border)—without letting logistics override medicine

Cardiac packet - Prior 12-lead ECGs (PDF photos OK if official copies pending) - Cardiology notes, echo reports, device history if any - Personal/family sudden death, long QT, syncope history

Labs (if recently done; otherwise program may order) - Electrolytes (potassium, magnesium; calcium as indicated) - Renal/hepatic panels as clinically relevant - Other labs your clinicians already track

Medication & supplement list (complete) - Prescription psych meds, cardiac meds, antibiotics, antiemetics - OTCs, herbs, “detox” powders, stimulants, cannabis products - Last dose times—without DIY stopping

Educational caution only: /blog/ibogaine-ssri-psychiatric-meds (not a taper plan).

Substance-use & withdrawal timeline - Primary substances, last use, prior complicated withdrawals - MOUD history (methadone/buprenorphine/naltrexone) if relevant - Alcohol/benzo dependence flags (medical withdrawal risk)

Condition context: /ibogaine-for-addiction · Comparisons: /blog/ibogaine-vs-naltrexone · /blog/ibogaine-vs-ketamine-for-addiction.

Psychiatric & trauma history - Diagnoses, hospitalizations, current therapists - PTSD/depression goals stated without cure expectations: /ibogaine-for-ptsd · /ibogaine-for-depression

Aftercare draft - Who meets you on return? Therapy slots? Peer support? - See /blog/ibogaine-aftercare-integration

Questions you should ask them (while they ask you)

1. Who is the physician of record during infusion?
2. Continuous ECG/telemetry duration? ACLS readiness? Transfer plan?
3. Is psychoactive dose IV, oral, or mixed—in writing?
4. How is support IV magnesium/fluids labeled vs psychoactive IV?
5. What happens if QTc or labs fail—refund/reschedule policy?
6. Will they refuse “guaranteed cure” language?

Telemetry: /blog/ibogaine-telemetry-acls-monitoring · Mortality/cardiac: /blog/ibogaine-mortality-cardiac-risk · Side effects: /blog/ibogaine-side-effects · Clinic choice: /blog/how-to-choose-an-ibogaine-clinic · Luxury red flags: /blog/ibogaine-luxury-retreat-red-flags · Mexico medical vs tourism: /blog/ibogaine-mexico-medical-vs-tourism · Cure claims: /blog/ibogaine-cure-rate-claims · Stanford oral+Mg label: /blog/stanford-ibogaine-mistic · Legal: /blog/is-ibogaine-legal-us · Cost: /blog/cost-of-ibogaine-treatment · Family: /blog/family-guide-ibogaine-treatment.

What “pass screening” does not mean

| It means | It does not mean | |----------|------------------| | Acute contraindications were not obvious on review | Zero cardiac risk | | Monitoring plan is acceptable to the team | FDA approval | | You understood route and consent | Guaranteed addiction/PTSD/depression cure | | Support IV may be used | Support IV is the medicine |

Oral literature reminder: Knuijver oral QTc signals; Cherian/MISTIC oral + IV Mg—inform risk thinking, do not prove psychoactive IV safety or efficacy.

Week-before logistics (still not medical clearance)

• Confirm how ECG files will be shared securely
• Arrange a sober support person who knows the emergency plan
• Avoid last-minute stimulant “productivity” stacks or mystery supplements
• Do not interpret a sales email saying “you’re approved pending deposit” as a cardiology clearance
• Re-read side-effect and monitoring pages so consent is informed, not theatrical

If cross-border care is in view, separate provisional Mexico availability from FDA/US clinic status. Medical infrastructure questions still dominate tourism amenities.

Common preparation mistakes

• Stopping psychiatric meds from a forum timeline before talking to prescribers
• Booking nonrefundable luxury packages before ECG
• Assuming ketamine-clinic vibes equal ibogaine telemetry capability
• Hiding fentanyl/benzo use to avoid “judgment”
• Treating Mexico provisional availability as FDA equivalence
• Confusing Cherian/MISTIC oral + IV Mg with psychoactive IV proof

How to organize files so screening goes faster

Create one folder (cloud or USB) named `ibogaine-screening-YYYY-MM`:

1. `01-med-list.pdf` — pharmacy printout
2. `02-ecg/` — prior tracings
3. `03-cardiology-notes/`
4. `04-labs/` — electrolytes and metabolic panels
5. `05-psych-summary.pdf` — short clinician letter if available
6. `06-substance-timeline.txt` — honest dates; no minimization
7. `07-questions-for-clinic.txt` — your telemetry/ACLS/route questions

Share only through channels the clinic’s privacy practice allows. Do not post ECGs in public Facebook groups for strangers to “read your QTc.”

Honesty rule: If you used fentanyl yesterday, say so. If you skipped doses of buprenorphine, say so. Screening teams would rather reschedule than resuscitate.

Pair with family support boundaries: /blog/family-guide-ibogaine-treatment.

Red flags during the screening process itself

• “You’re approved” before any ECG review
• Requests to hide psychiatric medicines from the physician “so you qualify”
• Refusal to put psychoactive route in writing
• Pressure to wire funds the same day as the first sales call
• Dismissal of QTc questions as fear-mongering
• Treating Cherian/MISTIC oral + IV magnesium as proof you can skip telemetry

If you see these, slow down and reread /blog/ibogaine-luxury-retreat-red-flags and /blog/ibogaine-mortality-cardiac-risk. Screening is allowed to end in “not now.” That outcome can be the most protective one available.

Soft CTA

Gather records first. Read /safety-and-screening, then request a confidential screening consult via /apply.

FAQ

What is the most important document to bring? A complete medication/supplement list plus any prior ECGs and cardiac history.

Can screening say no? Yes. Decline/delay is a valid safety outcome.

Do I need labs before the first call? Bring what you have; programs may require or repeat labs. Don’t invent DIY panels as a substitute for physician orders.

Should I taper meds before screening? Do not DIY taper. Discuss only with licensed clinicians.

Is IV ibogaine the same as a magnesium drip? No. Psychoactive IV ibogaine ≠ support IV magnesium/fluids.

Does passing screening guarantee results? No. No cure/guarantee claims.

Is ibogaine legal/FDA-approved in the U.S.? Schedule I federally; not FDA-approved.

What next? /safety-and-screening → /apply · /faq.

Medical disclaimer

Educational preparation guide only—not medical advice and not a clearance letter. Do not self-administer ibogaine. Ibogaine can cause life-threatening cardiac events. Seek licensed clinicians. Ibogaine is U.S. Schedule I and not FDA-approved.

Sources (selected)

1. Knuijver T. et al. *Addiction*. 2021 — oral ibogaine HCl; QTc open-label findings.
2. Cherian K.N. et al. *Nature Medicine*. 2024 — oral ibogaine + IV magnesium (MISTIC); open-label.
3. Mosca A. et al. *Current Neuropharmacology* — limited RCTs; cardiotoxicity concerns.
4. 21 CFR 1308.11 — Schedule I (ibogaine).